Navigation Links
LifeVantage to Present at Rodman & Renshaw Annual Global Investment Conference
Date:8/31/2011

SALT LAKE CITY, Aug. 31, 2011 /PRNewswire/ -- LifeVantage Corporation (OTCBB: LFVN), makers of Protandim®, the Nrf2 Synergizer™ patented dietary supplement, announced today that Douglas C. Robinson, the Company's President and Chief Executive Officer, and Dr. Joe McCord, the Company's Chief Science Officer, will be presenting at the Rodman & Renshaw Annual Global Investment Conference, to be held on September 11-13, 2011, at the Waldorf Astoria in New York.

(Logo: http://photos.prnewswire.com/prnh/20090930/LIFEVANTAGELOGO)  

The LifeVantage investor presentation is scheduled for Tuesday, September 13, 2011, at 9:10 am Eastern Time.  The presentation will be webcast live and archived at www.LifeVantage.com. Visitors to the website should select the "Investor Info" link to access the webcast.

At the Rodman & Renshaw Annual Global Investment Conference, more than 520 public & private companies from around the world are registered to present in front of an audience of over 4,000 attendees. The conference will feature tracks devoted to Healthcare, China, Metals & Mining, Energy, Technology, Cleantech, Financial Services, Israel and Growth/Special Situations. Al Gore, 45th Vice President of the United States, will open the Conference as the Keynote Speaker on Monday, September 12, 2011. Additional highlights of the conference include a speech by Henry Kissinger, 56th United States Secretary of State, who will address the audience as a special Guest Speaker on Tuesday, September 13, 2011. Dr. Kissinger's speech will be followed by corporate presentations, Q & A sessions, investor one-on-one meetings and daily networking opportunities.

About LifeVantage Corporation

LifeVantage, (OTCBB: LFVN), makers of Protandim®, the Nrf2 Synergizer™ patented dietary supplement, is a science based nutraceutical company. LifeVantage is dedicated to visionary science that promises to transform wellness and anti-aging internally and externally with supplements that dramatically reduce oxidative stress at the cellular level. The Company was founded in 2003 and currently has operations in Salt Lake City, Utah and San Diego, CA. For more information, visit www.LifeVantage.com.

Investor Relations Contact:
Cindy England (801) 432-9036
Director of Investor Relations
-or-
John Mills (310) 954-1105
Senior Managing Director, ICR, LLC


'/>"/>
SOURCE LifeVantage Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. LifeVantage Announces Preliminary Third Quarter 2011 Revenue
2. LifeVantage Announces Settlement of Zrii Litigation
3. LifeVantage Announces Unaudited First Quarter Fiscal 2010 Financial and Operating Results
4. LifeVantage Announces Preliminary Unaudited First Quarter Revenue
5. LifeVantage Announces Fourth Quarter and Fiscal Year 2009 Financial and Operating Results
6. Echo Therapeutics to Present at the Stifel Nicolaus Healthcare Conference 2011
7. BioDelivery Sciences Announces Upcoming Presentations at Three Investor Conferences
8. Elbit Imaging Announces Availability of Investor Relations Presentation - Analysis Sources and Uses
9. Inovio Pharmaceuticals to Present at Investor Conferences
10. Watson to Present at the 2011 Morgan Stanley Global Healthcare Conference
11. Luminex Corporation to Present at Upcoming Investment Conferences In September
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2016)... Mo. , May 3, 2016 ... Medical Center,s Institute for Advancing Medical Innovation (IAMI) ... commercialize new drugs, diagnostics and medical devices. ... BioNovus Innovations with rights to license, develop and ... "This partnership represents a ...
(Date:5/3/2016)... Ore. , May 3, 2016   ... medical technology, today announced Food and Drug Administration ... resynchronization defibrillator that provides heart failure patients with ... Iperia devices also have remote monitoring with daily ... adapts the heart rate in response to physiological ...
(Date:5/3/2016)... According to market research "Global ... and Demand Forecast to 2022 - Industry Insights by ... Very High Field, Low to Mid Field, and Ultra ... Musculoskeletal, Vascular, Breast, Pelvic and Abdomen, Cardiac, and Other)" ... market was valued at $5,351.7 million in 2015, and ...
Breaking Medicine Technology:
(Date:5/4/2016)... ... May 04, 2016 , ... ... 2016, a powerful cellular therapy software application that helps blood and marrow transplant ... , Since Transtem’s initial launch, Mediware has continued to enhance core application features. ...
(Date:5/4/2016)... ... May 04, 2016 , ... International Conference on Obesity and ... 2016 at Las Vegas. It aims to bring together academicians, scientists, dietitians, surgeons, ... organizations across the globe; making the conference a perfect platform to share experience ...
(Date:5/3/2016)... ... May 04, 2016 , ... The National Association of Professional Women (NAPW) ... of the Year Circle. She is recognized with this prestigious distinction for leadership in ... than 850,000 members and over 200 operating Local Chapters. , “I’m pleased to welcome ...
(Date:5/3/2016)... ... , ... Sue Desmond-Hellmann, chief executive officer of the Bill & Melinda Gates ... possibility in her keynote address at Georgia State University’s spring commencement on ... rich experience as a scientist, physician and executive, Desmond-Hellmann leads the Gates Foundation’s efforts ...
(Date:5/3/2016)... Baltimore, Md. (PRWEB) , ... May 03, 2016 , ... ... devastating consequences of inappropriate or excessive levels of alcohol use. Alcohol and its ... fetal alcohol spectrum disorders to the susceptibility to strokes in those 65 years and ...
Breaking Medicine News(10 mins):